David Windley
Stock Analyst at Jefferies
(3.63)
# 831
Out of 5,133 analysts
199
Total ratings
67.54%
Success rate
14.77%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgrades: Buy | $253 → $313 | $276.59 | +13.16% | 19 | Dec 5, 2025 | |
| DEO Diageo | Downgrades: Neutral | n/a | $90.89 | - | 1 | Dec 3, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $340.51 | +20.11% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $599.21 | -24.90% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $240.86 | -6.58% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $180.15 | -2.86% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $18.40 | -48.37% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $218.82 | -10.89% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $260.77 | +0.86% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.72 | +59.88% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $46.39 | +31.49% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $17.66 | -32.05% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $276.02 | +52.89% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $181.82 | +63.35% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.62 | +506.60% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $374.97 | +61.08% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $572.75 | -34.53% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $18.99 | -18.38% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $233.21 | +15.78% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.39 | +65.07% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $272.91 | +96.40% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $20.73 | +39.89% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.25 | +3,320.69% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.99 | - | 5 | Oct 9, 2017 |
Humana
Dec 5, 2025
Upgrades: Buy
Price Target: $253 → $313
Current: $276.59
Upside: +13.16%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $90.89
Upside: -
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $340.51
Upside: +20.11%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $599.21
Upside: -24.90%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $240.86
Upside: -6.58%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $180.15
Upside: -2.86%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $18.40
Upside: -48.37%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $218.82
Upside: -10.89%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $260.77
Upside: +0.86%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.72
Upside: +59.88%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $46.39
Upside: +31.49%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $17.66
Upside: -32.05%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $276.02
Upside: +52.89%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $181.82
Upside: +63.35%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.62
Upside: +506.60%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $374.97
Upside: +61.08%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $572.75
Upside: -34.53%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $18.99
Upside: -18.38%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $233.21
Upside: +15.78%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.39
Upside: +65.07%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $272.91
Upside: +96.40%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $20.73
Upside: +39.89%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.25
Upside: +3,320.69%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.99
Upside: -